Product Categories
Country: | United States |
---|---|
Tel: | +1-781-999-5354 |
E-mail: | support@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36?Washington?Street |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
GSK-2881078;GSK 2881078;GSK2881078 | C14H13F3N2O2S | 1539314-06-1 | Details |
NDMC101 | C13H9ClFNO2 | 1308631-40-4 | Details |
TM5007 | C24H20N2O6S4 | 342595-05-5 | Details |
VK-II-36 | C26H26N2O5 | 955371-66-1 | Details |
2-hydroxy Flutamide | C11H11F3N2O4 | 52806-53-8 | Details |
WAY-647802 | C11H14N4O3 | 852225-20-8 | Details |
Q203;Telacebec;IAP6 | C29H28ClF3N4O2 | 1334719-95-7 | Details |
4i;5-HT3 antagonist-4i;CHEMBL1269981 | C16H12ClN3O | 930478-88-9 | Details |
Ixazomib citrate;MLN9708 | C20H23BCl2N2O9 | 1239908-20-3 | Details |
4BP-TQS | C18H17BrN2O2S | 360791-49-7 | Details |
BMS-919373;BMS919373;BMS 919373 | C25H20N6O2S | 1272353-82-8 | Details |
JNJ-63533054;JNJ63533054;JNJ 63533054 | C17H17ClN2O2 | 1802326-66-4 | Details |
Acanthopanaxoside B | C61H98O27 | 915792-03-9 | Details |
17-Hydroxyisolathyrol | C20H30O5 | 93551-00-9 | Details |
URB602 | C19H21NO2 | 565460-15-3 | Details |
(E)-3PO;3PO | C13H10N2O | 13309-08-5 | Details |
TTA-A2 | C20H21F3N2O2 | 953778-63-7 | Details |
OSU-T315;OSU-T315 (1,5-regioisomer);ILK-IN-2 | C30H30F3N5O | 2070015-22-2 | Details |
OICR-9429;OICR9429;OICR 9429 | C29H32F3N5O3 | 1801787-56-3 | Details |
SBI-0640756;SBI-756;SBI 0640756;SBI0640756 | C23H14ClFN2O2 | 1821280-29-8 | Details |
Vps34-PIK-III;PIK-III;VPS34-IN2 | C17H17N7 | 1383716-40-2 | Details |
BC-1382 | C23H29N3O5S | 1013753-99-5 | Details |
MK-1064;MK 1064;MK1064;Urokinase inhibitor 1 | C24H20ClN5O3 | 1207253-08-4 | Details |
SU 4942 | C15H10BrNO | 76086-99-2 | Details |
MS049 | C15H24N2O | 1502816-23-0 | Details |
RSL3;RSL3 1S;1S,3R-RSL3 | C23H21ClN2O5 | 1219810-16-8 | Details |
5-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | C13H11N3O4 | 191732-76-0 | Details |
3'-Deoxyguanosine | C10H13N5O4 | 3608-58-0 | Details |
SirReal2 | C22H20N4OS2 | 709002-46-0 | Details |
DL-Goitrin;Goitrin | C5H7NOS | 13190-34-6 | Details |
Cumene, m-ethyl- | C11H16 | 4920-99-4 | Details |
BI-9564;BI9564;BI 9564 | C20H23N3O3 | 1883429-22-8 | Details |
9-Oxooctadeca-10,12-dienoic acid;9-Oxo-10,12-octadecadienoic acid | C18H30O3 | 54232-58-5 | Details |
CXD101;CXD-101 | C24H29N5O | 934828-12-3 | Details |
Neuropeptide Y (human);Human neuropeptide Y (29-64);Neuropeptide Y (29-64), amide, human | C189H284N55O57RS | 90880-35-6 | Details |
Hypidone hydrochloride;YL0919 | C18H23ClN2O2 | 1339058-04-6 | Details |
NMS-P118 | C20H24F3N3O2 | 1262417-51-5 | Details |
Dihydrokavain;7,8-Dihydrokawain;7,8-Dihydrokavain;Marindinin | C14H16O3 | 587-63-3 | Details |
IACS-010759;IACS-10759;IACS10759;IACS 10759 | C25H25F3N6O4S | 1570496-34-2 | Details |
TAK-259 HCl;TAK-259;TAK259 | C14H14Cl3N3O3S | 1192347-42-4 | Details |
CHM-081;CHM 081;CHM081 | C27H27NO2 | 1373876-34-6 | Details |
MX69 | C27H26N2O4S | 1005264-47-0 | Details |
Phenazine methylsulfate;Phenazine methosulfate | C14H14N2O4S | 299-11-6 | Details |
GS-444217;GS 444217;GS444217 | C23H21N7O | 1262041-49-5 | Details |
Piperolein A | C19H25NO3 | 30505-92-1 | Details |
APS-2-79 hydrochloride;APS-2-79;APS-2-79 HCl | C23H22ClN3O3 | 2002381-31-7 | Details |
Thalidomide 4-fluoride;E3 ligase Ligand 4 | C13H9FN2O4 | 835616-60-9 | Details |
Parkeyl acetate | C32H52O2 | 55570-91-7 | Details |
Amcasertib;BBI503 | C31H33N5O2S | 1129403-56-0 | Details |
CFMTI | C19H16FN5O | 864864-17-5 | Details |
LY-228729 | C27H34N4O4 | 137641-36-2 | Details |
D-Arabinose | C5H10O5 | 10323-20-3 | Details |
V 2307;V-2307;V2307 | C15H11Cl3O3 | 101191-06-4 | Details |
Microfarin;Microcrystalline warfarin;Acid (enol) warfarin | C19H16O4 | 101468-14-8 | Details |
TC11;1H-Isoindole-1,3(2H)-dione, 5-amino-2-[2,6-bis(1-methylethyl)phenyl]-TC11;CLT-003 | C20H22N2O2 | 100823-03-8 | Details |
Y-29794 Tosylate;Y-29794;Y 29794 tosylate;Y29794;Y 29794;Y29794 tosylate | C30H42N2O4S3 | 143984-17-2 | Details |
Tebanicline hydrochloride;Ebanicline hydrochloride;ABT-594 hydrochloride | C9H12Cl2N2O | 203564-54-9 | Details |
FIN56 | C25H31N3O5S2 | 1083162-61-1 | Details |
Fenaminstrobin;SYP1620;SYP-1620;SYP 1620 | C21H21Cl2N3O3 | 366815-39-6 | Details |
Bay 41-4109 racemate | C18H13ClF3N3O2 | 298708-79-9 | Details |
EC330 | C30H32F2O2 | 2016795-77-8 | Details |
PF-CBP1 | C29H36N4O3 | 1962928-21-7 | Details |
Nudicaucin B | C47H76O17 | 211557-36-7 | Details |
Eupteleasaponin I | C52H82O21 | 290809-29-9 | Details |
PCC0208009;IDO-IN-2;DO-IN-2;IDO inhibitor 1 | C29H35N7O | 1668565-74-9 | Details |
Amifostine trihydrate;WR2721;Amifostine;Ethyol trihydrate | C5H17N2O4PS | 112901-68-5 | Details |
C29 | C16H15NO4 | 363600-92-4 | Details |
Pinocembrin-7-O-β-D-glucopyranoside;Pinocembrin 7-O-beta-D-glucoside | C21H22O9 | 75829-43-5 | Details |
Vilaprisan;BAY1002670;BAY-10-02670;BAY-1002670;BAY 10-02670;BAY 1002670;BAY10-02670 | C27H29F5O4S | 1262108-14-4 | Details |
Henagliflozin;SHR-3824;SHR 3824;SHR3824 | C22H24ClFO7 | 1623804-44-3 | Details |
Strontium Malonate;NBS101;NBS-101;NBS 101 | C3H4O4 | 63524-05-0 | Details |
Melflufen;J 1;Melphalan flufenamide;J-1;J1;Prodrug J-1, Melflufen, Melphalan flufenamide | C24H30Cl2FN3O3 | 380449-51-4 | Details |
Colchicine, deacetamido-5,6-didehydro-;Colchicine;deacetamido-6-dehydro- (7CI);Deacetamido-6-dehydrocolchicine | C20H20O5 | 14511-67-2 | Details |
Benzamide, N-(5-(p-aminophenoxy)pentyl)-N-methyl- | C19H24N2O2 | 102008-49-1 | Details |
Ampelopsin A | C28H22O7 | 130608-11-6 | Details |
AC 3092;AC-3092;AC3092 | C20H25N5O3 | 7558-14-7 | Details |
HSP70-IN-1 | C24H28N6O2S | 1268273-90-0 | Details |
Ellipticine hydrochloride;NSC 71795 (hydrochloride);Ellipticine HCl | C17H15ClN2 | 5081-48-1 | Details |
Nystatin A3;Fungicidin;Nystatin | C53H85NO20 | 62997-67-5 | Details |
Hemiasterlin;NSC 695242;NSC-695242;Milnamide B;NSC695242;(-)-Hemiasterlin | C30H46N4O4 | 157207-90-4 | Details |
Ganoderic acid C1 | C30H42O7 | 95311-97-0 | Details |
m-Dioxane, 5-methyl-4-phenyl-, cis- | C11H14O2 | 2033-27-4 | Details |
Neogrifolin | C22H32O2 | 23665-96-5 | Details |
Cis-ACBD;cis-1-aminocyclobutane-1,3-dicarboxylic acid | C6H9NO4 | 73550-55-7 | Details |
T3Inh-1 | C27H20N6O3 | 50440-30-7 | Details |
NSC127916;NSC 127916;NSC-127916 | C19H22N8O5 | 27150-04-5 | Details |
n-Decanohydroxamic acid;Decanohydroxamic acid;Caprinohydroxamic acid;N-Hydroxydecanamide | C10H21NO2 | 2259-85-0 | Details |
Jacareubin | C18H14O6 | 3811-29-8 | Details |
m-Anisidine, 4-((1-methylheptyl)oxy)-, hydrochloride | C15H26ClNO2 | 15382-67-9 | Details |
Lopobutan | C7H7NO14 | 6582-30-5 | Details |
Phytic acid;inositol polyphosphate;Fytic Acid;myo-Inositol, hexakis(dihydrogen phosphate);Inositol hexaphosphate;inositol hexakisphosphate | C6H18O24P6 | 83-86-3 | Details |
LS 34;LS34;LS-34 | C12H16BrN3S2 | 83726-79-8 | Details |
Ammonium, ((p-diethylmethylammonio)phenethyl)diethylmethyl-, diiodide | C18H34I2N2 | 63977-59-3 | Details |
NSC 341077;NSC341077;NSC-341077 | C35H43N11O14 | 73610-81-8 | Details |
Etoxybamide | C6H13NO3 | 66857-17-8 | Details |
Ditryptophenaline | C42H40N6O4 | 64947-43-9 | Details |
Pyranojacareubin | C23H20O6 | 78343-62-1 | Details |
Solven;Jamylene;Danthron - DSS;DSS-danthron | C34H47NaO11S | 8059-64-1 | Details |
Diacetyljervine;Jervine;NSC 406352;NSC406352;N-acetyl-;N,O-Diacetyljervine;NSC-406352 | C31H43NO5 | 7622-06-2 | Details |
Methyl heptadecanoate | C18H36O2 | 1731-92-6 | Details |
Product Total: Product Page: | ||||
73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 |